print this page

Clinical Trials: Patient Outcomes


A Randomized Double Blinded Controlled Trial of an Oral Nutritional Supplement Containing AN 777 in Older Hospitalized Patients (IRB# 357016-16)

(Patient Outcomes)
  • Principal Investor
    Howard Smithline, MD
  • Summary

    The purpose of this study is to evaluate the effects of drinking a high-protein, high-calorie oral nutritional supplement on you and your health; and to see if it reduces health care events such as the likelihood of getting sick again after being discharged.  

  • More Information

    Eligibility:

    If you are 65 years of age or older, have been admitted to the hospital within the last 72 hours and able to consume food and beverages by mouth you may qualify for this study.

  • Study Site Location
    Emergency Room Baystate Medical Center
  • Contact
    Fidela Blank
    413-794-8680
    Email